Research News

Members of UK Markey Cancer Center’s Community Advisory Board.

Markey’s Community Advisory Board advocates for research advances

May 30, 2025, 7:09 AM

The CAB meets regularly throughout the year to offer input on the Kentucky Cancer Needs Assessment, Markey’s strategic plan, research priorities and outreach activities.

Research nurse Heather Heath with Jenn and Tyrome Highfield inside the Precision Medicine Clinic at Markey Cancer Center.

Clinical trials make discovery happen at UK

May 20, 2025, 7:20 AM

At the University of Kentucky, clinical trials are essential to providing the most advanced care to our patients and communities.

From left, David Higdon, with his children Luke and Ashley, and wife Tonya, enjoys a family trip to Scotland

Ky. attorney defies brain cancer odds through Markey clinical trial

May 15, 2025, 7:26 AM

Following surgery to remove a tumor from his brain, David Higdon was offered the opportunity to participate in an NIH-funded clinical trial.

Research Advancing Kentucky: Providing crucial supports for researchers

May 2, 2025, 9:08 AM

With NIH support, Katherine Hartmann describes the vital work of the UK Center for Clinical and Translational Science (CCTS) for UK researchers and Kentucky communities.

Markey clinical trials offer ‘latest and greatest’ cancer treatments

Feb 25, 2025, 7:26 AM

During a recent roundtable discussion, Zhonglin Hao and Eddy Yang shared the importance of clinical trials and how they play a significant role in changing how providers approach cancer care.

UK Begins 1st Clinical Trial in the World for Newly Discovered Form of Dementia

Mar 16, 2022, 7:10 AM

The world’s first clinical trial for a form of dementia identified in 2019 is officially underway by researchers at the University of Kentucky's Sanders-Brown Center on Aging.

Results of Johnson & Johnson COVID-19 Vaccine Trial Announced

Feb 1, 2021, 1:44 PM

The Phase 3 randomized, double-blind, placebo-controlled clinical trial was designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen investigational COVID-19 vaccine candidate versus placebo. Approximately 45,000 people participated worldwide. The combined UK, Baptist and Norton site was among the top enrolling sites in the world.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

Jan 12, 2021, 8:18 AM

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

'Behind the Blue': Dr. Peter Nelson Discusses UK’s Leading Efforts on Alzheimer’s and Dementia Research

Nov 20, 2020, 8:27 AM

Dr. Peter Nelson, of the University of Kentucky’s Sanders-Brown Center on Aging, has spent the last 15 years in the Commonwealth helping to lead the fight against Alzheimer’s and dementia inducing brain disease.

UK and Baptist Health Lexington, Norton Health Care Begin Recruiting Participants for Phase 3 COVID-19 Investigational Vaccine Clinical Trial

Nov 5, 2020, 11:09 AM

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

Filter News

News type

Unit

Topic

Series